寿胎丸加味配合主动免疫治疗反复自然流产的临床研究  

Clinical research on treating recurrent spontaneous abortion with Shoutai Wan plus active immunization

作　　者：高倩倩[1] 马永[1] 张华[1] 王祖龙[1] 

机构地区：[1]河南省中医院,河南郑州450002

出　　处：《中医临床研究》2014年第20期42-43,45,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:观察运用寿胎丸加味配合主动免疫的方法在治疗反复自然流产(RSA)方面的临床疗效。方法:按随机数字表法(1∶1)将我院近几年生殖门诊80例反复自然流产的患者随机分为两组,各40例。对照组给予单纯主动免疫治疗,治疗组在对照组的基础上给予寿胎丸,8周为1个疗程。观察治疗前后CD3+、CD4+、CD8+细胞亚群比例并比较其差异性。结果:两组总有效率为82.50%和62.50%,两组临床疗效比较,Z=-4.071,P=0.000,治疗组优于对照组;两组患者治疗后CD3+、CD4+、CD8+细胞亚群均较前升高(P<0.05),且治疗组CD3+、CD8+优于对照组(P<0.05),两组CD4+比较无统计学差异。两组均无明显毒副作用。结论:寿胎丸加味配合主动免疫的方法在治疗RSA方面的临床疗效好,能够有效预防流产发生,且安全性比较高。To observe the clinical efficacy of Shoutai Wan plus active immunization on treating recurrent spontaneous abortion. Methods：80 patients were randomly divided into two groups. The control group was given active immunization treatment solo, and another was given Shoutai Wan more. Results：The total efficacy was 82.50%in the treatment group, better than 62.50%in the control;CD3＋, CD4＋, CD8＋ cell subsets in two groups were higher than before （P〈0.05）, and CD3＋, CD8＋ in the treatment group were better （P〈0.05）. There were no obvious side effects. Conclusion： Shoutai Wan plus active immunization come with confirmed clinical efficacy for RSA, it can effectively prevent abortion, and with relatively high safety.

关 键 词：主动免疫 寿胎丸 流产 

分 类 号：R169.4[医药卫生—公共卫生与预防医学]